Efficacy and safety of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E mutated biliary tract cancer (BTC): A cohort of the ROAR basket trial.

Wainberg, ZA; Lassen, UN; Elez, E; Italiano, A; Curigliano, G; De Braud, FG; Prager, G; Greil, R; Stein, A; Fasolo, A; Schellens, JHM; Wen, PY; Boran, AD; Burgess, P; Gasal, E; Ilankumaran, P; Subbiah, V

View this publication in the PUBMED database